﻿<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.irs.gov/efile" returnVersion="2018v3.1">
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2019-10-01T16:03:46-05:00</ReturnTs>
    <TaxPeriodEndDt>2019-06-30</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmEIN>320530003</PreparerFirmEIN>
      <PreparerFirmName>
        <BusinessNameLine1Txt>QUIGLEY &amp; MIRON</BusinessNameLine1Txt>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1Txt>3550 WILSHIRE BLVD 1660</AddressLine1Txt>
        <CityNm>LOS ANGELES</CityNm>
        <StateAbbreviationCd>CA</StateAbbreviationCd>
        <ZIPCd>90010</ZIPCd>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990</ReturnTypeCd>
    <TaxPeriodBeginDt>2018-07-01</TaxPeriodBeginDt>
    <Filer>
      <EIN>953890767</EIN>
      <BusinessName>
        <BusinessNameLine1Txt>SPONDYLITIS ASSOCIATION OF AMERICA</BusinessNameLine1Txt>
      </BusinessName>
      <BusinessNameControlTxt>SPON</BusinessNameControlTxt>
      <PhoneNum>8188921616</PhoneNum>
      <USAddress>
        <AddressLine1Txt>16360 ROSCOE BLVD NO 100</AddressLine1Txt>
        <CityNm>VAN NUYS</CityNm>
        <StateAbbreviationCd>CA</StateAbbreviationCd>
        <ZIPCd>91406</ZIPCd>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>CASSIE SHAFER</PersonNm>
      <PersonTitleTxt>CHIEF EXECUTIVE OFFICER</PersonTitleTxt>
      <PhoneNum>8188921616</PhoneNum>
      <SignatureDt>2019-10-01</SignatureDt>
    </BusinessOfficerGrp>
    <PreparerPersonGrp>
      <PreparerPersonNm>ARMEN GRIGORIAN</PreparerPersonNm>
      <PTIN>P01582463</PTIN>
      <PhoneNum>2136393550</PhoneNum>
    </PreparerPersonGrp>
    <FilingSecurityInformation>
      <IPAddress>
        <IPv4AddressTxt>99.88.83.161</IPv4AddressTxt>
      </IPAddress>
      <IPDt>2019-10-01</IPDt>
      <IPTm>14:02:56</IPTm>
      <IPTimezoneCd>PD</IPTimezoneCd>
      <FilingLicenseTypeCd>P</FilingLicenseTypeCd>
      <AtSubmissionCreationDeviceId>27FBF125226D956FC3DB72B33BF00386D94CACCB</AtSubmissionCreationDeviceId>
      <AtSubmissionFilingDeviceId>C1988052032BF7E796496D37049D37B62C620639</AtSubmissionFilingDeviceId>
    </FilingSecurityInformation>
    <TaxYr>2018</TaxYr>
    <BuildTS>2020-01-14 16:20:31Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCnt="7">
    <IRS990 documentId="RetDoc1038000001" referenceDocumentId="RetDoc1044400001">
      <PrincipalOfficerNm>CASSIE SHAFER</PrincipalOfficerNm>
      <USAddress>
        <AddressLine1Txt>16360 ROSCOE BLVD NO 100</AddressLine1Txt>
        <CityNm>VAN NUYS</CityNm>
        <StateAbbreviationCd>CA</StateAbbreviationCd>
        <ZIPCd>91406</ZIPCd>
      </USAddress>
      <GrossReceiptsAmt>2928682</GrossReceiptsAmt>
      <GroupReturnForAffiliatesInd>0</GroupReturnForAffiliatesInd>
      <Organization501c3Ind>X</Organization501c3Ind>
      <WebsiteAddressTxt>WWW.SPONDYLITIS.ORG</WebsiteAddressTxt>
      <TypeOfOrganizationCorpInd>X</TypeOfOrganizationCorpInd>
      <FormationYr>1983</FormationYr>
      <LegalDomicileStateCd>CA</LegalDomicileStateCd>
      <ActivityOrMissionDesc>ADVANCING RESEARCH, ACCELERATED DIAGNOSIS, OPTIMUM TREATMENT, PUBLIC AWARENESS AND HEALTH CARE PROFESSIONAL EDUCATION IN SPONDYLOARTHRITIS</ActivityOrMissionDesc>
      <VotingMembersGoverningBodyCnt>11</VotingMembersGoverningBodyCnt>
      <VotingMembersIndependentCnt>11</VotingMembersIndependentCnt>
      <TotalEmployeeCnt>13</TotalEmployeeCnt>
      <TotalVolunteersCnt>115</TotalVolunteersCnt>
      <TotalGrossUBIAmt>0</TotalGrossUBIAmt>
      <NetUnrelatedBusTxblIncmAmt>0</NetUnrelatedBusTxblIncmAmt>
      <PYContributionsGrantsAmt>2635511</PYContributionsGrantsAmt>
      <CYContributionsGrantsAmt>1941665</CYContributionsGrantsAmt>
      <PYProgramServiceRevenueAmt>5375</PYProgramServiceRevenueAmt>
      <CYProgramServiceRevenueAmt>8517</CYProgramServiceRevenueAmt>
      <PYInvestmentIncomeAmt>41534</PYInvestmentIncomeAmt>
      <CYInvestmentIncomeAmt>77928</CYInvestmentIncomeAmt>
      <PYOtherRevenueAmt>0</PYOtherRevenueAmt>
      <CYOtherRevenueAmt>0</CYOtherRevenueAmt>
      <PYTotalRevenueAmt>2682420</PYTotalRevenueAmt>
      <CYTotalRevenueAmt>2028110</CYTotalRevenueAmt>
      <PYGrantsAndSimilarPaidAmt>211316</PYGrantsAndSimilarPaidAmt>
      <CYGrantsAndSimilarPaidAmt>159994</CYGrantsAndSimilarPaidAmt>
      <PYBenefitsPaidToMembersAmt>0</PYBenefitsPaidToMembersAmt>
      <CYBenefitsPaidToMembersAmt>0</CYBenefitsPaidToMembersAmt>
      <PYSalariesCompEmpBnftPaidAmt>833268</PYSalariesCompEmpBnftPaidAmt>
      <CYSalariesCompEmpBnftPaidAmt>1099229</CYSalariesCompEmpBnftPaidAmt>
      <PYTotalProfFndrsngExpnsAmt>0</PYTotalProfFndrsngExpnsAmt>
      <CYTotalProfFndrsngExpnsAmt>0</CYTotalProfFndrsngExpnsAmt>
      <CYTotalFundraisingExpenseAmt>97371</CYTotalFundraisingExpenseAmt>
      <PYOtherExpensesAmt>790643</PYOtherExpensesAmt>
      <CYOtherExpensesAmt>845837</CYOtherExpensesAmt>
      <PYTotalExpensesAmt>1835227</PYTotalExpensesAmt>
      <CYTotalExpensesAmt>2105060</CYTotalExpensesAmt>
      <PYRevenuesLessExpensesAmt>847193</PYRevenuesLessExpensesAmt>
      <CYRevenuesLessExpensesAmt>-76950</CYRevenuesLessExpensesAmt>
      <TotalAssetsBOYAmt>3559276</TotalAssetsBOYAmt>
      <TotalAssetsEOYAmt>3526569</TotalAssetsEOYAmt>
      <TotalLiabilitiesBOYAmt>54813</TotalLiabilitiesBOYAmt>
      <TotalLiabilitiesEOYAmt>69711</TotalLiabilitiesEOYAmt>
      <NetAssetsOrFundBalancesBOYAmt>3504463</NetAssetsOrFundBalancesBOYAmt>
      <NetAssetsOrFundBalancesEOYAmt>3456858</NetAssetsOrFundBalancesEOYAmt>
      <InfoInScheduleOPartIIIInd>X</InfoInScheduleOPartIIIInd>
      <MissionDesc>ADVANCING AND DIRECTLY SPONSORING AXIAL SPONDYLOARTHRITIS RESEARCH, ACCELERATING DIAGNOSIS, SUPPORTING OPTIMUM TREATMENT FOR THE INDIVIDUAL, ADVANCING AWARENESS, AND PUBLIC AND HEALTH CARE PROFESSIONAL EDUCATION IN AXIAL SPONDYLOARTHRITIS.</MissionDesc>
      <SignificantNewProgramSrvcInd>0</SignificantNewProgramSrvcInd>
      <SignificantChangeInd>0</SignificantChangeInd>
      <ExpenseAmt>774984</ExpenseAmt>
      <RevenueAmt>8517</RevenueAmt>
      <Desc>EDUCATION AND AWARENESS - PATIENT CONFERENCES, SEMINARS, AND SUPPORT-THE ORGANIZATION SPONSORED PATIENT EDUCATION AND SUPPORT PROGRAMS THROUGH THE USE OF VARIOUS MEDIA. THE INTERACTIVE WEBSITE LOCATED AT SPONDYLITIS.ORG SERVES MORE THAN 500,000 UNIQUE VISITORS PER QUARTER BASED ON GOOGLE ANALYTICS REPORTS. PATIENT EDUCATION SEMINARS-PATIENT EDUCATION SEMINARS WERE HELD IN CHICAGO AND NEW YORK WITH LIVESTREAMING AVAILABLE AND WEBINARS RECORDED FOR FUTURE USE THROUGH THE WEBSITE. THIS AS LIFE LIVE (TASLL)- DAN REYNOLDS AND NOVARTIS PHARMACEUTICALS HAVE PARTNERED WITH THE ORGANIZATION TO BRING AN INTERACTIVE ONLINE TALK SHOW VIDEO SERIES, THIS AS LIFE LIVE (TASLL), TO LIFE. THE ORGANIZATION PROVIDES GUIDANCE ON THE PROJECT, SUGGESTS INTERVIEWEES, ATTENDS THE VIDEO SHOOTS, AND ENSURES ACCURACY OF SPA INFORMATION RECORDED AND SHARED. A TOTAL OF FIVE EPISODES WERE RELEASED DURING THE YEAR ENDED JUNE 30, 2019 AND A TOTAL OF 16 EPISODES HAVE BEEN RELEASED SINCE THE PROJECT LAUNCHED AT THE BEGINNING OF 2016.LIFE IMPACT SURVEY- A SURVEY WAS CONDUCTED WITH PATIENTS TO IDENTIFY THE PROPORTION OF PATIENTS WITH DELAYED DIAGNOSIS, REASONS, AND TREATMENT.SPONDYLITIS PLUS-MEMBERS OF THE SPONDYLITIS ASSOCIATION OF AMERICA RECEIVE A COPY OF THE ORGANIZATION'S PRINT PUBLICATION SPONDYLITIS PLUS FREE OF CHARGE, ON A QUARTERLY BASIS. MORE THAN 5,000 COPIES ARE DISTRIBUTED QUARTERLY.ESUN- MORE THAN 30,000 PEOPLE ARE SUBSCRIBED TO AND RECEIVE THE ORGANIZATION'S MONTHLY SPONDYLITIS EDUCATION AND AWARENESS E-NEWSLETTER.</Desc>
      <ProgSrvcAccomActy2Grp>
        <ExpenseAmt>288303</ExpenseAmt>
        <Desc>AWARENESS AND SUPPORT GROUPS- THE ORGANIZATION'S SUPPORT GROUPS CONTINUE TO BE ACTIVE ACROSS THE UNITED STATES, NUMBERING MORE THAN 43 GROUPS, 65 LEADERS IN 30 STATES WITH MORE THAN 200 MEETINGS HELD THROUGH JUNE 2019.</Desc>
      </ProgSrvcAccomActy2Grp>
      <ProgSrvcAccomActy3Grp>
        <ExpenseAmt>294158</ExpenseAmt>
        <GrantAmt>159994</GrantAmt>
        <Desc>RESEARCH EARLY CAREER INVESTIGATOR AWARDS (ECI)- ONE ECI AWARD WAS PRESENTED IN FY18-19 FOR $20,000. IT WAS AWARDED TO COLUMBIA UNIVERSITY MEDICAL CENTER:DR. RUNSHENG WANG RECEIVED THE ECI AWARD. DR. WANG IS AN ASSISTANT PROFESSOR OF MEDICINE AT COLUMBIA UNIVERSITY MEDICAL CENTER, A PAST LAWRENCE SHULMAN SCHOLAR AND ALSO A RESEARCH FELLOW AT NIH/NIAMS. EDUCATED AT DUKE UNIVERSITY SCHOOL OF MEDICINE AND PEKING UNION MEDICAL COLLEGE. SINCE 2014, SHE HAS PRESENTED AT MULTIPLE SPARTAN CONFERENCES WITH WORK IN HER INTEREST OF EPIDEMIOLOGY, EARLY DIAGNOSIS AND COMPARATIVE EFFECTIVENESS RESEARCH OF AXSPA. SHE HAS FIRST AUTHOR PAPERS ON AXSPA IN ARTHRITIS &amp; RHEUMATOLOGY, ANNALS OF RHEUMATIC DISEASES AND THE JOURNAL OF RHEUMATOLOGY. TAKING AN EPIDEMIOLOGY APPROACH, SHE HAS STUDIED THE NATURAL HISTORY OF AXIAL SPONDYLOARTHRITIS, AND SHOWED THAT ONLY A SMALL PROPORTION OF PATIENTS WITH NON-RADIOGRAPHIC AXIAL SPA WILL PROGRESS TO ANKYLOSING SPONDYLITIS. SHE ALSO CONDUCTED META-ANALYSIS OF CLINICAL TRIALS TO COMPARE THE EFFECT OF DIFFERENT TNF INHIBITORS, AND COMPARED EFFECT OF DIFFERENT NSAIDS. IN THE FUTURE, SHE WILL CONTINUE HER RESEARCH IN THE EPIDEMIOLOGY AND COMPARATIVE EFFECTIVENESS RESEARCH, TO BETTER UNDERSTAND THE EFFECTIVENESS AND SAFETY OF MEDICATIONS FOR AXIAL SPA IN THE REAL WORLD (RATHER THAN CLINICAL TRIAL SETTING) AND FOR INDIVIDUAL PATIENTS.IN ADDITION TO FUNDING ECI, THE ORGANIZATION RECEIVES FUNDING REQUESTS FROM OUTSIDE SOURCES TO SUPPORT RESEARCH RELATED TO SPONDYLITIS. BECAUSE THE ORGANIZATION HAS LIMITED RESOURCES FOR RESEARCH FUNDING, IT IS IMPERATIVE THAT ANY RESEARCH PROPOSALS MAKE OPTIMAL USE OF THE ORGANIZATION'S LIMITED RESOURCES. TWO FUNDING REQUESTS WERE APPROVED. FIRST, GOING TO UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSE, SCHOOL OF MEDICINE AND THE SECOND, TO STANFORD UNIVERSITY. - JOHN D. REVEILLE, MD, UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON, SCHOOL OF MEDICINE RECEIVED FUNDING FOR HIS BRIDGE GAP FUNDING REQUEST, "OUTCOME STUDIES IN ANKYLOSING SPONDYLITIS". THE PURPOSE OF THIS PROPOSAL IS TO ENSURE CONTINUED DATA MANAGEMENT AND STATISTICAL SUPPORT OF THE PROJECTS COMING FROM THE PROSPECTIVE STUDY OF OUTCOMES IN ANKYLOSING SPONDYLITIS (PSOAS) COHORT, WHICH WAS INITIALLY FUNDED BY NIH GRANTS R01 AR048465 (2001-2006), AND 1P01-052915 (2006-2011, 2012- 2017).- MARK CULLEN, MD, ALONG WITH INVESTIGATORS DRS WEISMAN, KUO AND KAPLAN, FOUNDATION FOR THE ADVANCEMENT OF MEDICINE RECEIVED FUNDING FOR THEIR GRANT REQUEST, "WORKPLACE ENVIRONMENTAL INFLUENCE AS RISK FOR DEVELOPING ANKYLOSING SPONDYLITIS: A PILOT PROJECT." THEY PROPOSED A CASE CONTROL STUDY TO IDENTIFY PATIENTS WITH AS DIAGNOSED AFTER A CERTAIN DATE AND EXAMINE AND CHARACTERIZE THEIR MAJOR RISK FOR HIGH PHYSICAL EXPOSURES AND COMPARE THEM TO PATIENTS WHO DO NOT HAVE A DIAGNOSIS OF AS (AT THE SAME DATES AS THE AS DIAGNOSIS) FOR THE SAME RISK FACTORS THEREFORE, THE MAIN PREMISE FOR THIS CURRENT STUDY IS IT COULD POSSIBLY RECAPITULATE THE ANIMAL STUDIES IN A HUMAN SITUATION WHERE WE MIGHT BE ABLE TO DEMONSTRATE THAT HEAVY PHYSICAL FORCE WOULD BE A FACTOR FOR BRINGING ABOUT THE ONSET OF AS IN A SUSCEPTIBLE POPULATION. FOR THE STUDY PROPOSED HEREIN THEY HAVE ACCESS TO A DATABASE THAT IS RICH AND WELL-CHARACTERIZED IN TWO ASPECTS OF EPIDEMIOLOGY THAT WOULD BE ESSENTIAL TO ADDRESS THE QUESTION OF THE ROLE OF PHYSICAL FORCE IN THE PRODUCTION OF AS. THEY WILL INVESTIGATE THESE QUESTIONS USING DATA FROM THE ALCOA STUDY. THIS UNIQUE LONGITUDINAL DATABASE IS CURATED BY THE CENTER FOR POPULATION HEALTH AT STANFORD UNIVERSITY.THE ORGANIZATION CONTINUES TO ADVANCE THE BELIEF THAT SUPPORTING RESEARCH WILL LEAD TO AN EVENTUAL CURE. IN THE SHORT-TERM, INSIGHTS GAINED FROM THESE STUDIES SHOULD ALSO EMPOWER AND ENGAGE CLINICIANS AND OTHERS IN THE MEDICAL COMMUNITY WITH OPPORTUNITIES TO CRITICALLY EVALUATE INFORMATION THROUGH, FOR EXAMPLE, PATIENT INTERVIEWS, PHYSICAL EXAMS, AND LABORATORY TESTS, IN ORDER TO FORMULATE A DIAGNOSIS AND DEVISE NEW TREATMENT OPTIONS.</Desc>
      </ProgSrvcAccomActy3Grp>
      <ProgSrvcAccomActyOtherGrp>
        <ExpenseAmt>360345</ExpenseAmt>
        <Desc>SOCIAL MEDIA- FACEBOOK AND TWITTER REMAIN A SOURCE OF EDUCATION AND AWARENESS WITH THE ORGANIZATION'S CONSTITUENTS. THE ORGANIZATION'S COMMUNITY FORUMS CONTINUE TO BE ACTIVE NOT ONLY FOR THE NEWLY-DIAGNOSED BUT THOSE LIVING WITH THIS DISEASE FROM A FEW YEARS TO ALMOST A LIFETIME. DURING THIS FISCAL YEAR, THE ORGANIZATION HELD TWO TWITTER CHATS AND TWO FACEBOOK LIVE EVENTS.PHYSICIAN EDUCATION-THE ORGANIZATION ATTENDED AND EXHIBITED AT SEVEN PHYSICIAN AND OTHER HEALTH CARE PROVIDER CONFERENCES IN THIS FISCAL YEAR. CONFERENCES INCLUDED:- THE RHEUMATOLOGY NURSES ASSOCIATION'S CONFERENCE, HELD IN AUGUST OF 2018, IN FORT WORTH, TX- THE AMERICA COLLEGE OF RHEUMATOLOGY CONFERENCE, HELD IN OCTOBER OF 2018, IN CHICAGO, IL- THE SPOKANE PAIN CONFERENCE HELD IN NOVEMBER OF 2018, IN SPOKANE, WA- THE PRI-MED CONFERENCE HELD IN DECEMBER OF 2018, IN BOSTON, MA- THE AMERICAN PHYSICAL THERAPY ASSOCIATION CONFERENCE, HELD IN JANUARY OF 2019, IN WASHINGTON, DC.- THE PRI-MED WEST CONFERENCE, HELD IN MAY OF 2019, IN ANAHEIM, CA.- THE PHYSICIAN ASSISTANTS CONFERENCE, HELD IN MAY OF 2019, IN DENVER, CO. MORE THAN 3,000 LEADS FOR ADDITIONAL INFORMATION FROM HEALTHCARE PROVIDERS HAVE BEEN GENERATED FROM THE ORGANIZATION'S ATTENDANCE TO DATE. SPONDYLOARTHRITIS RESEARCH AND TREATMENT NETWORK (SPARTAN)-EACH YEAR, THE ORGANIZATION PARTICIPATES IN THE SPARTAN CONFERENCE. IN MAY 2019, IT WAS HELD IN MADISON, WI. THE CONFERENCE INCLUDED CME TRAINING ON SPONDYLOARTHRITIS, SEVERAL PRESENTATIONS ON THE ROLE AND ADVANCEMENT OF IMAGING IN DIAGNOSIS AND MONITORING DISEASE PROGRESSION. EARLY CAREER INVESTIGATORS PRESENTED ORIGINAL SPONDYLOARTHRITIS RESEARCH. ONE OF THE KEY AREAS ON THE AGENDA WERE BREAKOUT SESSIONS DEVOTED TO DISCUSSIONS ON OUTREACH TO NON-RHEUMATOLOGIST HEALTH CARE PROVIDERS. EUROPEAN CONGRESS OF RHEUMATOLOGY (EULAR)-IN JUNE 2019, THE ORGANIZATION ATTENDED EULAR IN MADRID, SHARING EXHIBIT SPACE WITH THE ANKYLOSING SPONDYLITIS INTERNATIONAL FEDERATION (ASIF). THE ORGANIZATION MET WITH INTERNATIONAL STAKEHOLDERS INCLUDING RESEARCHERS, PATIENT ORGANIZATION REPRESENTATIVES, AND PHARMACEUTICAL COMPANIES THAT SUPPORT THE ORGANIZATION. ACR/SAA/SPARTAN TREATMENT GUIDELINES UPDATE-ACR AND THE ORGANIZATION ARE FUNDING PARTNERS IN THIS UPDATE, WHICH WAS RELEASED ONLINE IN AUGUST 2019. THE ORGANIZATION IDENTIFIED AND RECRUITED TWO PATIENTS TO BE INCLUDED ON THE VOTING PANEL TO REPRESENT THE PATIENT VOICE AND TAKE PART IN THE DECISION-MAKING PROCESS. THE ORGANIZATION REMAINED CLOSELY ENGAGED AND INVOLVED THROUGHOUT THE MEETING PROCESS, AND IS CURRENTLY WORKING ON CREATING A PATIENT FRIENDLY TRANSLATION OF THE COMPLETED UPDATED TREATMENT GUIDELINES. EDUCATIONAL MATERIAL UPDATES-DURING THIS FISCAL YEAR THE ORGANIZATION REVISED, REDESIGNED, AND REPRINTED SEVEN SPA EDUCATIONAL BROCHURES, INCLUDING: INFLAMMATORY VS. MECHANICAL BACK PAIN; IRITIS; ROLE OF EXERCISE IN SPA; JUVENILE SPA; JUST DIAGNOSED; OVERVIEW OF SPA; AXIAL SPA IN WOMEN; AS WELL AS OUR BOOKLET, GUIDE TO LIVING WITH ANKYLOSING SPONDYLITIS. BACK IN ACTION, AGAIN: NEW EXERCISE SERIES PLANNED, PRODUCED, AND DELIVERED TO OUR COMMUNITY-THE ORGANIZATION PRODUCED A NEW EXERCISE SERIES, COMPRISED OF THE FOLLOWING SEGMENTS:- MORNING AND EVENING STRETCH- CARDIO- STRENGTH - YOGA WORLD SPONDYLOARTHRITIS SUMMIT - THE ORGANIZATION PRODUCED AN ONLINE EDUCATIONAL EVENT WITH SIX DIFFERENT TOPICS, BEING BROADCAST OVER THE COURSE OF THREE DAYS. THE PRESENTERS, TOPIC FACILITATORS, AND TOPICS COVERED WERE: - DR. UTA KILTZ AND DON MARKHAM ON "COMPLICATIONS, RELATED CONDITIONS." - ANGELO PAPACHRISTOS, PT, AND ROSE BIGHAM ON "PHYSICAL THERAPY AND EXERCISE: BEST PRACTICES AND NOT-SO-BEST PRACTICES" - DR. ROBERT OVERBAUGH AND ROSE BIGHAM ON "OVERVIEW OF POSSIBLE CAUSES AND A COMPREHENSIVE APPROACH TO PAIN MANAGEMENT" - DR. MARK FISHER AND DON MARKHAM ON "DIET &amp; NUTRITION FOR SPA" - DR. JOHN D. REVEILLE AND ROSE BIGHAM ON "LATEST SPA RESEARCH: UPDATES FROM AROUND THE WORLD"- DR. HILLARY NORTON AND ELIZABETH MAINES, PH.D ON "MEDICATIONS: NAVIGATING MEDICAL MANAGEMENT OF SPAUNIVERSITY PILOT PROGRAM: THINK SPA - ACCELERATING DIAGNOSIS AMONG 18 - 23 YEAR OLD'S. -THE ORGANIZATION PILOTED A HEALTH CARE PROFESSIONAL (HCP) OUTREACH PROGRAM ON A COLLEGE CAMPUS. IN FEBRUARY OF 2019 THE ORGANIZATIONAL HELD AN HCP EDUCATIONAL PROGRAM AT THE HEALTH SERVICES DEPARTMENT AT CAL POLY POMONA UNIVERSITY IN CALIFORNIA GEARED TO HELPING STUDENT CLINIC STAFF BETTER RECOGNIZE SIGNS AND SYMPTOMS OF SPA IN UNDIAGNOSED STUDENTS. A SECOND STAGE OF THE PROGRAM, TAKING PLACE IN THE SPRING OF 2019, FOCUSED ON REACHING THE STUDENT BODY THEMSELVES, AND INVOLVED OUTREACH THROUGH EYE-CATCHING ADS AND POSTS IN THEIR STUDENT PRINT PUBLICATION, ONLINE PUBLICATION, AS WELL AS SOCIAL MEDIA. THE ORGANIZATION CREATED THE CONTENT AND PAID FOR THE PLACEMENT OF THESE ADS AND POSTS.</Desc>
      </ProgSrvcAccomActyOtherGrp>
      <TotalOtherProgSrvcExpenseAmt>360345</TotalOtherProgSrvcExpenseAmt>
      <TotalProgramServiceExpensesAmt>1717790</TotalProgramServiceExpensesAmt>
      <DescribedInSection501c3Ind referenceDocumentId="RetDoc1039100001">1</DescribedInSection501c3Ind>
      <ScheduleBRequiredInd referenceDocumentId="RetDoc1234500001">1</ScheduleBRequiredInd>
      <PoliticalCampaignActyInd>0</PoliticalCampaignActyInd>
      <LobbyingActivitiesInd>0</LobbyingActivitiesInd>
      <SubjectToProxyTaxInd>0</SubjectToProxyTaxInd>
      <DonorAdvisedFundInd referenceDocumentId="RetDoc1040000001">0</DonorAdvisedFundInd>
      <ConservationEasementsInd referenceDocumentId="RetDoc1040000001">0</ConservationEasementsInd>
      <CollectionsOfArtInd referenceDocumentId="RetDoc1040000001">0</CollectionsOfArtInd>
      <CreditCounselingInd referenceDocumentId="RetDoc1040000001">0</CreditCounselingInd>
      <TempOrPermanentEndowmentsInd referenceDocumentId="RetDoc1040000001">0</TempOrPermanentEndowmentsInd>
      <ReportLandBuildingEquipmentInd referenceDocumentId="RetDoc1040000001">1</ReportLandBuildingEquipmentInd>
      <ReportInvestmentsOtherSecInd referenceDocumentId="RetDoc1040000001">0</ReportInvestmentsOtherSecInd>
      <ReportProgramRelatedInvstInd referenceDocumentId="RetDoc1040000001">0</ReportProgramRelatedInvstInd>
      <ReportOtherAssetsInd referenceDocumentId="RetDoc1040000001">0</ReportOtherAssetsInd>
      <ReportOtherLiabilitiesInd referenceDocumentId="RetDoc1040000001">0</ReportOtherLiabilitiesInd>
      <IncludeFIN48FootnoteInd referenceDocumentId="RetDoc1040000001">1</IncludeFIN48FootnoteInd>
      <IndependentAuditFinclStmtInd referenceDocumentId="RetDoc1040000001">1</IndependentAuditFinclStmtInd>
      <ConsolidatedAuditFinclStmtInd referenceDocumentId="RetDoc1040000001">0</ConsolidatedAuditFinclStmtInd>
      <SchoolOperatingInd>0</SchoolOperatingInd>
      <ForeignOfficeInd>0</ForeignOfficeInd>
      <ForeignActivitiesInd>0</ForeignActivitiesInd>
      <MoreThan5000KToOrgInd>0</MoreThan5000KToOrgInd>
      <MoreThan5000KToIndividualsInd>0</MoreThan5000KToIndividualsInd>
      <ProfessionalFundraisingInd>0</ProfessionalFundraisingInd>
      <FundraisingActivitiesInd>0</FundraisingActivitiesInd>
      <GamingActivitiesInd>0</GamingActivitiesInd>
      <OperateHospitalInd>0</OperateHospitalInd>
      <GrantsToOrganizationsInd referenceDocumentId="RetDoc1041900001">1</GrantsToOrganizationsInd>
      <GrantsToIndividualsInd referenceDocumentId="RetDoc1041900001">0</GrantsToIndividualsInd>
      <ScheduleJRequiredInd referenceDocumentId="RetDoc1042400001">1</ScheduleJRequiredInd>
      <TaxExemptBondsInd>0</TaxExemptBondsInd>
      <EngagedInExcessBenefitTransInd>0</EngagedInExcessBenefitTransInd>
      <PYExcessBenefitTransInd>0</PYExcessBenefitTransInd>
      <LoanOutstandingInd>0</LoanOutstandingInd>
      <GrantToRelatedPersonInd>0</GrantToRelatedPersonInd>
      <BusinessRlnWithOrgMemInd>0</BusinessRlnWithOrgMemInd>
      <BusinessRlnWithFamMemInd>0</BusinessRlnWithFamMemInd>
      <BusinessRlnWithOfficerEntInd>0</BusinessRlnWithOfficerEntInd>
      <DeductibleNonCashContriInd>0</DeductibleNonCashContriInd>
      <DeductibleArtContributionInd>0</DeductibleArtContributionInd>
      <TerminateOperationsInd>0</TerminateOperationsInd>
      <PartialLiquidationInd>0</PartialLiquidationInd>
      <DisregardedEntityInd>0</DisregardedEntityInd>
      <RelatedEntityInd>0</RelatedEntityInd>
      <RelatedOrganizationCtrlEntInd>0</RelatedOrganizationCtrlEntInd>
      <TrnsfrExmptNonChrtblRltdOrgInd>0</TrnsfrExmptNonChrtblRltdOrgInd>
      <ActivitiesConductedPrtshpInd>0</ActivitiesConductedPrtshpInd>
      <ScheduleORequiredInd>1</ScheduleORequiredInd>
      <IRPDocumentCnt>8</IRPDocumentCnt>
      <IRPDocumentW2GCnt>0</IRPDocumentW2GCnt>
      <EmployeeCnt>13</EmployeeCnt>
      <EmploymentTaxReturnsFiledInd>1</EmploymentTaxReturnsFiledInd>
      <UnrelatedBusIncmOverLimitInd>0</UnrelatedBusIncmOverLimitInd>
      <ForeignFinancialAccountInd>0</ForeignFinancialAccountInd>
      <ProhibitedTaxShelterTransInd>0</ProhibitedTaxShelterTransInd>
      <TaxablePartyNotificationInd>0</TaxablePartyNotificationInd>
      <NondeductibleContributionsInd>0</NondeductibleContributionsInd>
      <QuidProQuoContributionsInd>0</QuidProQuoContributionsInd>
      <Form8282PropertyDisposedOfInd>0</Form8282PropertyDisposedOfInd>
      <RcvFndsToPayPrsnlBnftCntrctInd>0</RcvFndsToPayPrsnlBnftCntrctInd>
      <PayPremiumsPrsnlBnftCntrctInd>0</PayPremiumsPrsnlBnftCntrctInd>
      <IndoorTanningServicesInd>0</IndoorTanningServicesInd>
      <SubjToTaxRmnrtnExPrchtPymtInd>0</SubjToTaxRmnrtnExPrchtPymtInd>
      <SubjectToExcsTaxNetInvstIncInd>0</SubjectToExcsTaxNetInvstIncInd>
      <InfoInScheduleOPartVIInd>X</InfoInScheduleOPartVIInd>
      <GoverningBodyVotingMembersCnt>11</GoverningBodyVotingMembersCnt>
      <IndependentVotingMemberCnt>11</IndependentVotingMemberCnt>
      <FamilyOrBusinessRlnInd>0</FamilyOrBusinessRlnInd>
      <DelegationOfMgmtDutiesInd>0</DelegationOfMgmtDutiesInd>
      <ChangeToOrgDocumentsInd>0</ChangeToOrgDocumentsInd>
      <MaterialDiversionOrMisuseInd>0</MaterialDiversionOrMisuseInd>
      <MembersOrStockholdersInd>0</MembersOrStockholdersInd>
      <ElectionOfBoardMembersInd>0</ElectionOfBoardMembersInd>
      <DecisionsSubjectToApprovaInd>0</DecisionsSubjectToApprovaInd>
      <MinutesOfGoverningBodyInd>1</MinutesOfGoverningBodyInd>
      <MinutesOfCommitteesInd>1</MinutesOfCommitteesInd>
      <OfficerMailingAddressInd>0</OfficerMailingAddressInd>
      <LocalChaptersInd>0</LocalChaptersInd>
      <Form990ProvidedToGvrnBodyInd>1</Form990ProvidedToGvrnBodyInd>
      <ConflictOfInterestPolicyInd>1</ConflictOfInterestPolicyInd>
      <AnnualDisclosureCoveredPrsnInd>1</AnnualDisclosureCoveredPrsnInd>
      <RegularMonitoringEnfrcInd>1</RegularMonitoringEnfrcInd>
      <WhistleblowerPolicyInd>1</WhistleblowerPolicyInd>
      <DocumentRetentionPolicyInd>1</DocumentRetentionPolicyInd>
      <CompensationProcessCEOInd>1</CompensationProcessCEOInd>
      <CompensationProcessOtherInd>1</CompensationProcessOtherInd>
      <InvestmentInJointVentureInd>0</InvestmentInJointVentureInd>
      <StatesWhereCopyOfReturnIsFldCd>CA</StatesWhereCopyOfReturnIsFldCd>
      <OwnWebsiteInd>X</OwnWebsiteInd>
      <OtherWebsiteInd>X</OtherWebsiteInd>
      <UponRequestInd>X</UponRequestInd>
      <BooksInCareOfDetail>
        <BusinessName>
          <BusinessNameLine1Txt>CASSIE SHAFER</BusinessNameLine1Txt>
        </BusinessName>
        <PhoneNum>8188921616</PhoneNum>
        <USAddress>
          <AddressLine1Txt>16360 ROSCOE BLVD</AddressLine1Txt>
          <CityNm>VAN NUYS</CityNm>
          <StateAbbreviationCd>CA</StateAbbreviationCd>
          <ZIPCd>91406</ZIPCd>
        </USAddress>
      </BooksInCareOfDetail>
      <Form990PartVIISectionAGrp>
        <PersonNm>ELLEN CARROLL</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>CRAIG GIMBEL</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>ERIC GOLDSTEIN</PersonNm>
        <TitleTxt>VICE CHAIR, TREASURER</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>DAVID HALLEGUA</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>CHARLOTTE K HOWARD</PersonNm>
        <TitleTxt>SECRETARY</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>MARY ANN POLADIAN</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>PAULA OLSIEWSKI</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>MICHAEL PIANIN</PersonNm>
        <TitleTxt>BOARD CHAIR</TitleTxt>
        <AverageHoursPerWeekRt>2.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>RANDALL SAPADIN</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>JOHN D REVEILLE</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>JAMES ROSENBAUM</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>CASSIE SHAFER</PersonNm>
        <TitleTxt>CHIEF EXECUTIVE OFFICER</TitleTxt>
        <AverageHoursPerWeekRt>40.00</AverageHoursPerWeekRt>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>197776</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>3509</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <TotalReportableCompFromOrgAmt>197776</TotalReportableCompFromOrgAmt>
      <TotReportableCompRltdOrgAmt>0</TotReportableCompRltdOrgAmt>
      <TotalOtherCompensationAmt>3509</TotalOtherCompensationAmt>
      <IndivRcvdGreaterThan100KCnt>1</IndivRcvdGreaterThan100KCnt>
      <FormerOfcrEmployeesListedInd>0</FormerOfcrEmployeesListedInd>
      <TotalCompGreaterThan150KInd>1</TotalCompGreaterThan150KInd>
      <CompensationFromOtherSrcsInd>0</CompensationFromOtherSrcsInd>
      <CntrctRcvdGreaterThan100KCnt>0</CntrctRcvdGreaterThan100KCnt>
      <AllOtherContributionsAmt>1941665</AllOtherContributionsAmt>
      <NoncashContributionsAmt>5490</NoncashContributionsAmt>
      <TotalContributionsAmt>1941665</TotalContributionsAmt>
      <ProgramServiceRevenueGrp>
        <Desc>PUBLICATION SALES</Desc>
        <BusinessCd>611710</BusinessCd>
        <TotalRevenueColumnAmt>8517</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>8517</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <TotalProgramServiceRevenueAmt>8517</TotalProgramServiceRevenueAmt>
      <InvestmentIncomeGrp>
        <TotalRevenueColumnAmt>68076</TotalRevenueColumnAmt>
        <ExclusionAmt>68076</ExclusionAmt>
      </InvestmentIncomeGrp>
      <GrossAmountSalesAssetsGrp>
        <SecuritiesAmt>910424</SecuritiesAmt>
      </GrossAmountSalesAssetsGrp>
      <LessCostOthBasisSalesExpnssGrp>
        <SecuritiesAmt>900572</SecuritiesAmt>
      </LessCostOthBasisSalesExpnssGrp>
      <GainOrLossGrp>
        <SecuritiesAmt>9852</SecuritiesAmt>
      </GainOrLossGrp>
      <NetGainOrLossInvestmentsGrp>
        <TotalRevenueColumnAmt>9852</TotalRevenueColumnAmt>
        <ExclusionAmt>9852</ExclusionAmt>
      </NetGainOrLossInvestmentsGrp>
      <TotalRevenueGrp>
        <TotalRevenueColumnAmt>2028110</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>8517</RelatedOrExemptFuncIncomeAmt>
        <UnrelatedBusinessRevenueAmt>0</UnrelatedBusinessRevenueAmt>
        <ExclusionAmt>77928</ExclusionAmt>
      </TotalRevenueGrp>
      <GrantsToDomesticOrgsGrp>
        <TotalAmt>159994</TotalAmt>
        <ProgramServicesAmt>159994</ProgramServicesAmt>
      </GrantsToDomesticOrgsGrp>
      <CompCurrentOfcrDirectorsGrp>
        <TotalAmt>196914</TotalAmt>
        <ProgramServicesAmt>157532</ProgramServicesAmt>
        <ManagementAndGeneralAmt>19691</ManagementAndGeneralAmt>
        <FundraisingAmt>19691</FundraisingAmt>
      </CompCurrentOfcrDirectorsGrp>
      <OtherSalariesAndWagesGrp>
        <TotalAmt>749197</TotalAmt>
        <ProgramServicesAmt>603838</ProgramServicesAmt>
        <ManagementAndGeneralAmt>95796</ManagementAndGeneralAmt>
        <FundraisingAmt>49563</FundraisingAmt>
      </OtherSalariesAndWagesGrp>
      <PensionPlanContributionsGrp>
        <TotalAmt>23759</TotalAmt>
        <ProgramServicesAmt>19120</ProgramServicesAmt>
        <ManagementAndGeneralAmt>2904</ManagementAndGeneralAmt>
        <FundraisingAmt>1735</FundraisingAmt>
      </PensionPlanContributionsGrp>
      <OtherEmployeeBenefitsGrp>
        <TotalAmt>59166</TotalAmt>
        <ProgramServicesAmt>48112</ProgramServicesAmt>
        <ManagementAndGeneralAmt>7175</ManagementAndGeneralAmt>
        <FundraisingAmt>3879</FundraisingAmt>
      </OtherEmployeeBenefitsGrp>
      <PayrollTaxesGrp>
        <TotalAmt>70193</TotalAmt>
        <ProgramServicesAmt>56856</ProgramServicesAmt>
        <ManagementAndGeneralAmt>8423</ManagementAndGeneralAmt>
        <FundraisingAmt>4914</FundraisingAmt>
      </PayrollTaxesGrp>
      <FeesForServicesAccountingGrp>
        <TotalAmt>65127</TotalAmt>
        <ManagementAndGeneralAmt>65127</ManagementAndGeneralAmt>
      </FeesForServicesAccountingGrp>
      <FeesForServicesOtherGrp>
        <TotalAmt>209064</TotalAmt>
        <ProgramServicesAmt>209064</ProgramServicesAmt>
      </FeesForServicesOtherGrp>
      <OfficeExpensesGrp>
        <TotalAmt>213141</TotalAmt>
        <ProgramServicesAmt>151508</ProgramServicesAmt>
        <ManagementAndGeneralAmt>57007</ManagementAndGeneralAmt>
        <FundraisingAmt>4626</FundraisingAmt>
      </OfficeExpensesGrp>
      <InformationTechnologyGrp>
        <TotalAmt>64822</TotalAmt>
        <ProgramServicesAmt>61022</ProgramServicesAmt>
        <ManagementAndGeneralAmt>2200</ManagementAndGeneralAmt>
        <FundraisingAmt>1600</FundraisingAmt>
      </InformationTechnologyGrp>
      <OccupancyGrp>
        <TotalAmt>85241</TotalAmt>
        <ProgramServicesAmt>58241</ProgramServicesAmt>
        <ManagementAndGeneralAmt>21800</ManagementAndGeneralAmt>
        <FundraisingAmt>5200</FundraisingAmt>
      </OccupancyGrp>
      <TravelGrp>
        <TotalAmt>101762</TotalAmt>
        <ProgramServicesAmt>92463</ProgramServicesAmt>
        <ManagementAndGeneralAmt>6476</ManagementAndGeneralAmt>
        <FundraisingAmt>2823</FundraisingAmt>
      </TravelGrp>
      <ConferencesMeetingsGrp>
        <TotalAmt>68679</TotalAmt>
        <ProgramServicesAmt>67039</ProgramServicesAmt>
        <FundraisingAmt>1640</FundraisingAmt>
      </ConferencesMeetingsGrp>
      <DepreciationDepletionGrp>
        <TotalAmt>31611</TotalAmt>
        <ProgramServicesAmt>26611</ProgramServicesAmt>
        <ManagementAndGeneralAmt>3300</ManagementAndGeneralAmt>
        <FundraisingAmt>1700</FundraisingAmt>
      </DepreciationDepletionGrp>
      <OtherExpensesGrp>
        <Desc>STATE LICENSING</Desc>
        <TotalAmt>6390</TotalAmt>
        <ProgramServicesAmt>6390</ProgramServicesAmt>
      </OtherExpensesGrp>
      <TotalFunctionalExpensesGrp>
        <TotalAmt>2105060</TotalAmt>
        <ProgramServicesAmt>1717790</ProgramServicesAmt>
        <ManagementAndGeneralAmt>289899</ManagementAndGeneralAmt>
        <FundraisingAmt>97371</FundraisingAmt>
      </TotalFunctionalExpensesGrp>
      <CashNonInterestBearingGrp>
        <BOYAmt>201472</BOYAmt>
        <EOYAmt>438692</EOYAmt>
      </CashNonInterestBearingGrp>
      <SavingsAndTempCashInvstGrp>
        <BOYAmt>2921894</BOYAmt>
        <EOYAmt>2592887</EOYAmt>
      </SavingsAndTempCashInvstGrp>
      <AccountsReceivableGrp>
        <BOYAmt>65971</BOYAmt>
        <EOYAmt>131743</EOYAmt>
      </AccountsReceivableGrp>
      <PrepaidExpensesDefrdChargesGrp>
        <BOYAmt>12571</BOYAmt>
        <EOYAmt>9491</EOYAmt>
      </PrepaidExpensesDefrdChargesGrp>
      <LandBldgEquipCostOrOtherBssAmt>59940</LandBldgEquipCostOrOtherBssAmt>
      <LandBldgEquipAccumDeprecAmt>45385</LandBldgEquipAccumDeprecAmt>
      <LandBldgEquipBasisNetGrp>
        <BOYAmt>9823</BOYAmt>
        <EOYAmt>14555</EOYAmt>
      </LandBldgEquipBasisNetGrp>
      <InvestmentsPubTradedSecGrp>
        <BOYAmt>254351</BOYAmt>
        <EOYAmt>271087</EOYAmt>
      </InvestmentsPubTradedSecGrp>
      <IntangibleAssetsGrp>
        <BOYAmt>87753</BOYAmt>
        <EOYAmt>62673</EOYAmt>
      </IntangibleAssetsGrp>
      <OtherAssetsTotalGrp>
        <BOYAmt>5441</BOYAmt>
        <EOYAmt>5441</EOYAmt>
      </OtherAssetsTotalGrp>
      <TotalAssetsGrp>
        <BOYAmt>3559276</BOYAmt>
        <EOYAmt>3526569</EOYAmt>
      </TotalAssetsGrp>
      <AccountsPayableAccrExpnssGrp>
        <BOYAmt>54813</BOYAmt>
        <EOYAmt>69711</EOYAmt>
      </AccountsPayableAccrExpnssGrp>
      <TotalLiabilitiesGrp>
        <BOYAmt>54813</BOYAmt>
        <EOYAmt>69711</EOYAmt>
      </TotalLiabilitiesGrp>
      <OrganizationFollowsSFAS117Ind>X</OrganizationFollowsSFAS117Ind>
      <UnrestrictedNetAssetsGrp>
        <BOYAmt>2799272</BOYAmt>
        <EOYAmt>2793479</EOYAmt>
      </UnrestrictedNetAssetsGrp>
      <TemporarilyRstrNetAssetsGrp>
        <BOYAmt>705191</BOYAmt>
        <EOYAmt>663379</EOYAmt>
      </TemporarilyRstrNetAssetsGrp>
      <TotalNetAssetsFundBalanceGrp>
        <BOYAmt>3504463</BOYAmt>
        <EOYAmt>3456858</EOYAmt>
      </TotalNetAssetsFundBalanceGrp>
      <TotLiabNetAssetsFundBalanceGrp>
        <BOYAmt>3559276</BOYAmt>
        <EOYAmt>3526569</EOYAmt>
      </TotLiabNetAssetsFundBalanceGrp>
      <ReconcilationRevenueExpnssAmt>-76950</ReconcilationRevenueExpnssAmt>
      <NetUnrlzdGainsLossesInvstAmt>29345</NetUnrlzdGainsLossesInvstAmt>
      <OtherChangesInNetAssetsAmt>0</OtherChangesInNetAssetsAmt>
      <InfoInScheduleOPartXIIInd>X</InfoInScheduleOPartXIIInd>
      <MethodOfAccountingAccrualInd>X</MethodOfAccountingAccrualInd>
      <AccountantCompileOrReviewInd>0</AccountantCompileOrReviewInd>
      <FSAuditedInd>1</FSAuditedInd>
      <FSAuditedBasisGrp>
        <SeparateBasisFinclStmtInd>X</SeparateBasisFinclStmtInd>
      </FSAuditedBasisGrp>
      <AuditCommitteeInd>1</AuditCommitteeInd>
      <FederalGrantAuditRequiredInd>0</FederalGrantAuditRequiredInd>
    </IRS990>
    <IRS990ScheduleA documentId="RetDoc1039100001">
      <PublicOrganization170Ind>X</PublicOrganization170Ind>
      <GiftsGrantsContriRcvd170Grp>
        <CurrentTaxYearMinus4YearsAmt>1395463</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>1334632</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>1666271</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>1652738</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>1941665</CurrentTaxYearAmt>
        <TotalAmt>7990769</TotalAmt>
      </GiftsGrantsContriRcvd170Grp>
      <TotalCalendarYear170Grp>
        <CurrentTaxYearMinus4YearsAmt>1395463</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>1334632</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>1666271</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>1652738</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>1941665</CurrentTaxYearAmt>
        <TotalAmt>7990769</TotalAmt>
      </TotalCalendarYear170Grp>
      <SubstantialContributorsTotAmt>2856797</SubstantialContributorsTotAmt>
      <PublicSupportTotal170Amt>5133972</PublicSupportTotal170Amt>
      <GrossInvestmentIncome170Grp>
        <CurrentTaxYearMinus4YearsAmt>15420</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>24573</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>25145</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>35065</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>68076</CurrentTaxYearAmt>
        <TotalAmt>168279</TotalAmt>
      </GrossInvestmentIncome170Grp>
      <TotalSupportAmt>8159048</TotalSupportAmt>
      <GrossReceiptsRltdActivitiesAmt>45762</GrossReceiptsRltdActivitiesAmt>
      <PublicSupportCY170Pct>0.62920</PublicSupportCY170Pct>
      <PublicSupportPY170Pct>0.67580</PublicSupportPY170Pct>
      <ThirtyThrPctSuprtTestsCY170Ind>X</ThirtyThrPctSuprtTestsCY170Ind>
      <Form990ScheduleAPartVIGrp>
        <FormAndLineReferenceDesc>SCHEDULE A, PART VI, LIST OF UNUSUAL GRANTS:</FormAndLineReferenceDesc>
        <ExplanationTxt>DESCRIPTION: CONTRIBUTION DATE: 06/30/18 AMOUNT: 982773. DESCRIPTION: BEQUEST DATE: 06/30/15 AMOUNT: 381349.</ExplanationTxt>
      </Form990ScheduleAPartVIGrp>
    </IRS990ScheduleA>
    <IRS990ScheduleB documentId="RetDoc1234500001" />
    <IRS990ScheduleD documentId="RetDoc1040000001">
      <EquipmentGrp>
        <OtherCostOrOtherBasisAmt>48446</OtherCostOrOtherBasisAmt>
        <DepreciationAmt>35225</DepreciationAmt>
        <BookValueAmt>13221</BookValueAmt>
      </EquipmentGrp>
      <OtherLandBuildingsGrp>
        <OtherCostOrOtherBasisAmt>11494</OtherCostOrOtherBasisAmt>
        <DepreciationAmt>10160</DepreciationAmt>
        <BookValueAmt>1334</BookValueAmt>
      </OtherLandBuildingsGrp>
      <TotalBookValueLandBuildingsAmt>14555</TotalBookValueLandBuildingsAmt>
      <FootnoteTextInd>X</FootnoteTextInd>
      <TotalRevEtcAuditedFinclStmtAmt>2057455</TotalRevEtcAuditedFinclStmtAmt>
      <NetUnrealizedGainsInvstAmt>29345</NetUnrealizedGainsInvstAmt>
      <RevenueNotReportedAmt>29345</RevenueNotReportedAmt>
      <RevenueSubtotalAmt>2028110</RevenueSubtotalAmt>
      <RevenueNotReportedFinclStmtAmt>0</RevenueNotReportedFinclStmtAmt>
      <TotalRevenuePerForm990Amt>2028110</TotalRevenuePerForm990Amt>
      <TotExpnsEtcAuditedFinclStmtAmt>2105060</TotExpnsEtcAuditedFinclStmtAmt>
      <ExpensesNotReportedAmt>0</ExpensesNotReportedAmt>
      <ExpensesSubtotalAmt>2105060</ExpensesSubtotalAmt>
      <ExpensesNotRptFinclStmtAmt>0</ExpensesNotRptFinclStmtAmt>
      <TotalExpensesPerForm990Amt>2105060</TotalExpensesPerForm990Amt>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART X, LINE 2:</FormAndLineReferenceDesc>
        <ExplanationTxt>ACCOUNTING STANDARDS REQUIRE AN ORGANIZATION TO EVALUATE ITS TAX POSITIONS AND PROVIDE FOR A LIABILITY FOR ANY POSITIONS THAT WOULD NOT BE CONSIDERED 'MORE LIKELY THAN NOT' TO BE UPHELD UNDER A TAX AUTHORITY EXAMINATION. MANAGEMENT HAS EVALUATED ITS TAX POSITIONS AND HAS CONCLUDED THAT A PROVISION FOR A TAX LIABILITY IS NOT NECESSARY AT JUNE 30, 2019. GENERALLY, THE ORGANIZATION'S INFORMATION RETURNS REMAIN OPEN FOR EXAMINATION FOR A PERIOD OF THREE (FEDERAL) OR FOUR (STATE OF CALIFORNIA) YEARS FROM THE DATE OF FILING.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleD>
    <IRS990ScheduleI documentId="RetDoc1041900001">
      <GrantRecordsMaintainedInd>1</GrantRecordsMaintainedInd>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>UNIVERSITY OF TEXAS HEALTH SCIENCES</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>PO BOX 301418</AddressLine1Txt>
          <CityNm>DALLAS</CityNm>
          <StateAbbreviationCd>TX</StateAbbreviationCd>
          <ZIPCd>75303</ZIPCd>
        </USAddress>
        <RecipientEIN>741761309</RecipientEIN>
        <IRCSectionDesc>501(C)(3)</IRCSectionDesc>
        <CashGrantAmt>100000</CashGrantAmt>
        <PurposeOfGrantTxt>OUTCOME STUDIES IN AS</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>COLUMBIA UNIVERSITY MEDICAL IRVING CENTER</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>630 W 168 ST PS 3-450</AddressLine1Txt>
          <CityNm>NEW YORK</CityNm>
          <StateAbbreviationCd>NY</StateAbbreviationCd>
          <ZIPCd>10032</ZIPCd>
        </USAddress>
        <RecipientEIN>135598093</RecipientEIN>
        <IRCSectionDesc>501(C)(3)</IRCSectionDesc>
        <CashGrantAmt>20000</CashGrantAmt>
        <PurposeOfGrantTxt>EARLY INVESTIGATOR AWARD (JBRF)</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>STANFORD CENTER FOR POPULATION HEALTH</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>291 CAMPUS DR 321B</AddressLine1Txt>
          <CityNm>STANFORD</CityNm>
          <StateAbbreviationCd>CA</StateAbbreviationCd>
          <ZIPCd>94305</ZIPCd>
        </USAddress>
        <RecipientEIN>941156365</RecipientEIN>
        <IRCSectionDesc>501(C)(3)</IRCSectionDesc>
        <CashGrantAmt>39994</CashGrantAmt>
        <PurposeOfGrantTxt>WORKPLACE ENVIRONMENT AS RISK FOR DEVELOP. AS</PurposeOfGrantTxt>
      </RecipientTable>
      <Total501c3OrgCnt>3</Total501c3OrgCnt>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART I, LINE 2:</FormAndLineReferenceDesc>
        <ExplanationTxt>RESEARCHERS ARE REQUIRED TO PROVIDE THE ORGANIZATION WITH PROGRESS REPORTS BASED ON A VARIETY OF MILESTONES INDIVIDUAL TO EACH STUDY, AND TO ENSURE THAT ANY PUBLICATION IN PEER REVIEW ACKNOWLEDGES THE ORGANIZATION'S FUNDING SUPPORT TOWARD THE EFFORT.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleI>
    <IRS990ScheduleJ documentId="RetDoc1042400001">
      <BoardOrCommitteeApprovalInd>X</BoardOrCommitteeApprovalInd>
      <SeverancePaymentInd>0</SeverancePaymentInd>
      <SupplementalNonqualRtrPlanInd>0</SupplementalNonqualRtrPlanInd>
      <EquityBasedCompArrngmInd>0</EquityBasedCompArrngmInd>
      <CompBasedOnRevenueOfFlngOrgInd>0</CompBasedOnRevenueOfFlngOrgInd>
      <CompBsdOnRevRelatedOrgsInd>0</CompBsdOnRevRelatedOrgsInd>
      <CompBsdNetEarnsFlngOrgInd>0</CompBsdNetEarnsFlngOrgInd>
      <CompBsdNetEarnsRltdOrgsInd>0</CompBsdNetEarnsRltdOrgsInd>
      <AnyNonFixedPaymentsInd>0</AnyNonFixedPaymentsInd>
      <InitialContractExceptionInd>0</InitialContractExceptionInd>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>CASSIE SHAFER</PersonNm>
        <TitleTxt>CHIEF EXECUTIVE OFFICER</TitleTxt>
        <BaseCompensationFilingOrgAmt>197776</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>0</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>0</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>0</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>0</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>0</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>2856</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>0</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>653</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>0</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>201285</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>0</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>0</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
    </IRS990ScheduleJ>
    <IRS990ScheduleO documentId="RetDoc1044400001">
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 11B</FormAndLineReferenceDesc>
        <ExplanationTxt>THE AUDIT COMMITTEE REVIEWS THE DOCUMENT PRIOR TO ITS DISTRIBUTION TO THE ENTIRE BOARD FOR REVIEW.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 12C</FormAndLineReferenceDesc>
        <ExplanationTxt>ALL DIRECTORS AND SENIOR EMPLOYEES ARE REQUIRED TO COMPLETE AND SIGN A DISCLOSURE FORM LISTING ANY POTENTIAL CONFLICTS OF INTEREST BY SEPTEMBER 30, ANNUALLY.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 15</FormAndLineReferenceDesc>
        <ExplanationTxt>THE ORGANIZATION UTILIZES CURRENT COMPENSATION DATA PUBLISHED BY THE NATIONAL HEALTH COUNCIL AND THE AMERICAN SOCIETY OF ASSOCIATION EXECUTIVES, AND OTHER FACTORS IN ORDER TO DETERMINE COMPENSATION.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION C, LINE 19</FormAndLineReferenceDesc>
        <ExplanationTxt>THE ORGANIZATION PRODUCES AN ANNUAL REPORT THAT IS PUBLISHED ON ITS WEBSITE</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART XII, LINE 2C</FormAndLineReferenceDesc>
        <ExplanationTxt>THE ORGANIZATION'S AUDIT COMMITTEE HAS RESPONSIBILITY FOR THE OVERSIGHT OF THE AUDIT OF ITS FINANCIAL STATEMENTS AND SELECTION OF THE INDEPENDENT AUDITOR, SUBJECT TO THE APPROVAL OF THE BOARD OF DIRECTORS. THIS RESPONSIBILITY IS UNCHANGED FROM THE PRIOR YEAR.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleO>
  </ReturnData>
</Return>